Hepatitis C lipo-viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell

PLoS ONE

Volumn 2, Issue 3, 2007, Pages

  Agaugué, Sophie ^a,b,d   Perrin Cocon, Laure ^a,b   André, Patrice ^a,b,c   Lotteau, Vincent ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d Department of Experimental Medicine (DIMES)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 6; LIPOPROTEIN VIRUS PARTICLE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; CYTOKINE; LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; CELL MATURATION; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; PHENOTYPE; POLARIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VIRUS PARTICLE; VIRUS REPLICATION; BLOOD; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE; MIXED LYMPHOCYTE CULTURE; MONOCYTE; PATHOLOGY; PHYSIOLOGY;

HEPATITIS C VIRUS;

CYTOKINES; DENDRITIC CELLS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIPOPROTEINS; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MONOCYTES; PHENOTYPE; RNA, VIRAL; TOLL-LIKE RECEPTOR 4; TRIGLYCERIDES; VIRAL PROTEINS;

EID: 44949183323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000330     Document Type: Article

References (60)

1. Hoofnagle JH (1997) Hepatitis C: the clinical spectrum of disease. Hepatology 26: 15S-20S.
2. Reed KE, Rice CM (2000) Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242: 55-84.
3. Randall G, Rice CM (2001) Hepatitis C virus cell culture replication systems: their potential use for the development of antiviral therapies. Curr Opin Infect Dis 14: 743-747.
4. Zeisel MB, Baumert TF (2006) Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied research. J Hepatol 44: 436-439.
5. Andre P, Perlemuter G, Budkowska A, Brechot C, Lotteau V (2005) Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis 25: 93-104.
6. Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, et al. (2002) Characterization of low- and very-low-density hepatitis C virus RNA- containing particles. J Virol 76: 6919-6928.
7. Nielsen SU, Bassendine MF, Burt AD, Bevitt DJ, Toms GL (2004) Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver. J Gen Virol 85: 1497-1507.
8. Nielsen SU, Bassendine MF, Burt AD, Martin C, Pumeechockchai W, et al. (2006) Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol 80: 2418-2428.
9. Diaz O, Delers F, Maynard M, Demignot S, Zoulim F, et al. (2006) Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins. J Gen Virol 87: 2983-2991.
10. Price DA, Bassendine MF, Norris SM, Golding C, Toms GL, et al. (2006) Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut 55: 715-718.
11. Deforges S, Evlashev A, Perret M, Sodoyer M, Pouzol S, et al. (2004) Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo. J Gen Virol 85: 2515-2523.
12. Bochkov VN, Leitinger N (2003) Anti-inflammatory properties of lipid oxidation products. J Mol Med 81: 613-626.
13. Furnkranz A, Leitinger N (2004) Regulation of inflammatory responses by oxidized phospholipids: structure-function relationships. Curr Pharm Des 10: 915-921.
14. Shaw PX (2004) Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it. Arch Immunol Ther Exp (Warsz) 52: 225-239.
15. Coutant F, Perrin-Cocon L, Agaugue S, Delair T, Andre P, et al. (2002) Mature dendritic cell generation promoted by lysophosphatidylcholine. J Immunol 169: 1688-1695.
16. Coutant F, Agaugue S, Perrin-Cocon L, Andre P, Lotteau V (2004) Sensing environmental lipids by dendritic cell modulates its function. J Immunol 172: 54-60.
17. Perrin-Cocon L, Coutant F, Agaugue S, Deforges S, Andre P, et al. (2001) Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J Immunol 167: 3785-3791.
18. Luo Y, Liang C, Xu C, Jia Q, Huang D, et al. (2004) Ciglitazone inhibits oxidized-low density lipoprotein induced immune maturation of dendritic cells. J Cardiovasc Pharmacol 44: 381-385.
19. Perrin-Cocon L, Agaugue S, Coutant F, Saint-Mezard P, Guironnet-Paquet A, et al. (2006) Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses. Vaccine 24: 1254-1263.
20. van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, et al. (2002) A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 277: 48122-48129.
21. Schwarzer E, Kuhn H, Valente E, Arese P (2003) Malaria-parasitized erythrocytes and hemozoin nonenzymatically generate large amounts of hydroxy fatty acids that inhibit monocyte functions. Blood 101: 722-728.
22. Skorokhod OA, Alessio M, Mordmuller B, Arese P, Schwarzer E (2004) Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect. J Immunol 173: 4066-4074.
23. Goodridge HS, Marshall FA, Wilson EH, Houston KM, Liew FY, et al. (2004) In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype. Immunology 113: 491-498.
24. Goodridge HS, Marshall FA, Else KJ, Houston KM, Egan C, et al. (2005) Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J Immunol 174: 284-293.
25. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, et al. (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102: 2992-2997.
26. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, et al. (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1: 398-401.
27. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR (2002) Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A 99: 2281-2286.
28. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, et al. (2001) Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 75: 10730-10737.
29. Jude BA, Pobezinskaya Y, Bishop J, Parke S, Medzhitov RM, et al. (2003) Subversion of the innate immune system by a retrovirus. Nat Immunol 4: 573-578.
30. Komurian-Pradel F, Paranhos-Baccala G, Sodoyer M, Chevallier P, Mandrand B, et al. (2001) Quantitation of HCV RNA using real-time PCR and fluorimetry. J Virol Methods 95: 111-119.
31. Dussaix E, Lebon P, Ponsot G, Huault G, Tardieu M (1985) Intrathecal synthesis of different alpha-interferons in patients with various neurological diseases. Acta Neurol Scand 71: 504-509.
32. Komurian-Pradel F, Perret M, Deiman B, Sodoyer M, Lotteau V, et al. (2004) Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome. J Virol Methods 116: 103-106.
33. Larsson M, Beignon AS, Bhardwaj N (2004) DC-virus interplay: a double edged sword. Semin Immunol 16: 147-161.
34. Ardeshna KM, Pizzey AR, Devereux S, Khwaja A (2000) The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 96: 1039-1046.
35. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C (2001) A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 166: 3837-3845.
36. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P (1998) Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 188: 2175-2180.
37. Puig-Kroger A, Relloso M, Fernandez-Capetillo O, Zubiaga A, Silva A, et al. (2001) Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 98: 2175-2182.
38. Anthony DD, Yonkers NL, Post AB, Asaad R, Heinzel FP, et al. (2004) Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol 172: 4907-4916.
39. Auffermann-Gretzinger S, Keeffe EB, Levy S (2001) Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97: 3171-3176.
40. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, et al. (2001) Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120: 512-524.
41. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, et al. (1999) Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162: 5584-5591.
42. Longman RS, Talal AH, Jacobson IM, Albert ML, Rice CM (2004) Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103: 1026-1029.
43. Longman RS, Talal AH, Jacobson IM, Rice CM, Albert ML (2005) Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis 192: 497-503.
44. Piccioli D, Tavarini S, Nuti S, Colombatto P, Brunetto M, et al. (2005) Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J Hepatol 42: 61-67.
45. Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, et al. (2004) Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190: 1919-1926.
46. Kanto T, Inoue M, Miyazaki M, Itose I, Miyatake H, et al. (2006) Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels. Intervirology 49: 58-63.
47. Fang SH, Chiang BL, Wu MH, Iba H, Lai MY, et al. (2001) Functional measurement of hepatitis C virus core-specific CD8(+) T-cell responses in the livers or peripheral blood of patients by using autologous peripheral blood mononuclear cells as targets or stimulators. J Clin Microbiol 39: 3895-3901.
48. He XS, Rehermann B, Lopez-Labrador FX, Boisvert J, Cheung R, et al. (1999) Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A 96: 5692-5697.
49. Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, et al. (2004) High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127: 924-936.
50. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, et al. (2003) Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171: 4984-4989.
51. Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, et al. (2004) Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 34: 796-805.
52. Goutagny N, Vieux C, Decullier E, Ligeoix B, Epstein A, et al. (2004) Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. J Infect Dis 189: 1646-1655.
53. Murakami H, Akbar SM, Matsui H, Horiike N, Onji M (2004) Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol 137: 559-565.
54. Jiang W, Sun R, Wei H, Tian Z (2005) Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc Natl Acad Sci U S A 102: 17077-17082.
55. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, et al. (2004) Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127: 1513-1524.
56. Bluml S, Kirchberger S, Bochkov VN, Kronke G, Stuhlmeier K, et al. (2005) Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol 175: 501-508.
57. Panther E, Idzko M, Corinti S, Ferrari D, Herouy Y, et al. (2002) The influence of lysophosphatidic acid on the functions of human dendritic cells. J Immunol 169: 4129-4135.
58. Walton KA, Cole AL, Yeh M, Subbanagounder G, Krutzik SR, et al. (2003) Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol 23: 1197-1203.
59. Zeyda M, Saemann MD, Stuhlmeier KM, Mascher DG, Nowotny PN, et al. (2005) Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation. J Biol Chem 280: 14293-14301.
60. Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174: 4453-4460.